A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity
Cardiovascular Research · 26.06.2026 · 122 (9) · 1206-1223
DOI: 10.1093/cvr/cvag112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 27.05.2026. Verfasst von Max J Cumberland und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Science, School of Medical Sciences, University of Birmingham, Edgbaston B15 2TT, UK. Hauptthemen laut MEDLINE: Connectin, Atrial Fibrillation, Myocytes, Cardiac, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, National Centre for the 3Rs and Industry, British Heart Foundation.
Abstract (Originalsprache)
Aims
Titin truncating variants (TTNtv) are a major genetic cause of dilated cardiomyopathy (DCM), accounting for approximately 25% of familial cases. Atrial fibrillation (AF) frequently occurs in DCM patients carrying TTNtv and may precede overt ventricular dysfunction, suggesting an atrial-specific disease mechanism. How TTNtv increase susceptibility to AF, particularly in the absence of established DCM, remains incompletely understood. This study aimed to define the cellular and molecular mechanisms by which a clinically relevant TTNtv predisposes to atrial arrhythmogenesis. Methods and results We introduced a patient-associated TTNtv (TTN c.59926+1G>A) into human induced pluripotent stem cell-derived atrial cardiomyocytes (hiPSC-CMs). TTNtv hiPSC-CMs exhibited proarrhythmic electrophysiological alterations, including increased spontaneous beating frequency, abnormal sodium channel kinetics, and heightened sensitivity to cholinergic agonists. In silico simulations demonstrated that heightened cholinergic sensitivity was sufficient to trigger AF under conditions of sinus tachycardia. RNA sequencing revealed dysregulation of sarcomere assembly and extracellular matrix pathways, and TTNtv hiPSC-CMs showed structurally shortened sarcomeres. Engineered heart tissues composed of TTNtv hiPSC-CMs co-cultured with cardiac fibroblasts demonstrated reduced contractile force and increased secretion of collagen, fibronectin-1 and TGF-β1, consistent with activation of profibrotic signalling. Together, these findings indicate that a TTNtv can cause intrinsic atrial electrical instability and promote pro-fibrotic signalling.
Conclusion
Our results identify atrial electrophysiological abnormalities and profibrotic remodelling as key mechanisms by which TTNtv increase AF risk, even in the absence of overt DCM. These findings support a primary atrial contribution to TTNtv-associated arrhythmogenesis and provide mechanistic insight into AF as an early clinical manifestation in carriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Science, School of Medical Sciences, University of Birmingham, Edgbaston B15 2TT, UK.
- Centre for Heart Research, The Westmead Institute for Medical Research, University of Sydney, 176 Hawkesbury Road, Westmead, NSW 2145, Australia.
- Department of Computer Science, British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford, UK.
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, and British Heart Foundation Centre of Research Excellence Oxford, University of Oxford, Oxford OX3 9DU, UK.
- Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Sydney, New South Wales, Australia.
- Centre of Membrane Proteins and Receptors (COMPARE), The Universities of Birmingham and Nottingham, The Midlands B15 2TT, UK.
ORCID-Profile: Max J Cumberland, Albert Dasí, Leto Riebel, Davor Pavlovic, Paulus Kirchhof, Chris Denning, Benjamin Davies, Andrew P Holmes, Katja Gehmlich
Förderung
- Medical Research Council
- National Centre for the 3Rs and Industry
- British Heart Foundation
- BHF
- NC3Rs Early Career Engagement Award
- Institute of Cardiovascular Sciences
- University of Birmingham
- European Commission Horizon 2020 research and innovation programme
Zitieren
APA
Cumberland, M. J., Dasí, A., Sontayananon, N., Marcus, A. D., Qin, A. R., Riebel, L., Euchner, J., Azad, A. J., Hall, C., O'Shea, C., Smith, J. G. W., Papadopoulou, C., Miska, E. A., Pavlovic, D., Patrick, E., Chong, J. J. H., Kirchhof, P., Denning, C., Davies, B., …, & Gehmlich, K. (2026). A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity. Cardiovascular Research, 122(9), 1206-1223. https://doi.org/10.1093/cvr/cvag112
Vancouver
Cumberland MJ, Dasí A, Sontayananon N, Marcus AD, Qin AR, Riebel L, et al. A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity. Cardiovascular Research. 2026;122(9):1206-1223. doi:10.1093/cvr/cvag112
BibTeX
@article{Cumberland2026,
author = {Cumberland, Max J and Dasí, Albert and Sontayananon, Naeramit and Marcus, Alan D and Qin, Alex R and Riebel, Leto and Euchner, Jonas and Azad, Amar J and Hall, Caitlin and O'Shea, Christopher and Smith, James G W and Papadopoulou, Charikleia and Miska, Eric A and Pavlovic, Davor and Patrick, Ellis and Chong, James J H and Kirchhof, Paulus and Denning, Chris and Davies, Benjamin and Rodriguez, Blanca and Holmes, Andrew P and Gehmlich, Katja},
title = {A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {9},
pages = {1206--1223},
doi = {10.1093/cvr/cvag112}
}
EUVIMED